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Abstract
Novel immune photoluminescent biosensor, based on TiO2 nanoparticles, for retroviral leucosis detection has been 
developed. The photoluminescence spectra were excited by solid state laser with wavelength 355 nm and measured in 
the range of 370-800 nm. Original photoluminescence spectrum of TiO2 nanoparticles showed wide maximum at 515 
nm. The biosensitive layer was formed by immobilization of retroviral leucosis antigens on the surface of TiO2
nanoparticles. Immobilization of antigens on TiO2 surface led to UV-shift of photoluminescence spectrum and 
increase of PL intensity. The response to different concentrations of retroviral leucosis antibodies has been measured. 
The decrease of spectrum intensity and IR-shift were observed after antibodies adsorption on biosensor surface. The 
experimental dependences of maximum shift and intensity changes versus antibodies concentration were obtained. 
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1. Introduction 
Bovine leucosis – is the highly foetal neoplasia of the cattle characterised by the abnormality 
maturation process of the blood cells and the aggregation of the neaplastic lymphocytes in the lymph 
nodes [1]. Clinical signs are most commonly associated with the infection and they include weight loss, 
decreased milk production, lymphadenopathy and posterior paresis. Virus of the type C (retrovirus family 
from an oncovirus rod) is the causative agent of the disease. Virus contains the revertase and six antigen 
proteins, among of which is the superficial (an envelope protein) glycoprotein (gp51) and the inside 
protein (p21) [2]. 
Diagnosis of the BLV infection based on the clinical signs alone is difficult because of the wide range 
of symptoms. More then 20 various variants from the haematological, histological [1] and up to use of the 
polymerise chain reaction (PCR) [3] as well as a different variants of the immunological methods, for 
example, the classical fluorescence [4], the immune diffusion [4], the radioimmune analysis [4], the 
immunoblot [5] were developed. The traditional immune methods have high specificity and sensitivity, 
but they take a lot of time, and require additional parameters such as the labelled molecules. This 
drawback can be overcome with the use of the modern instrumental analytical devices based on the 
biosensor technology. 
TiO2 is well known material for optical, catalytic and sensing applications. The development of 
various deposition techniques allows synthesis of novel titanium dioxide structures with dimensions on 
the nanometre scale. The decrease of the dimensions below certain levels may lead to the formation of 
quantum-size effects such as the absorbance edge shift and the room temperature photoluminescence (PL) 
peaks appearance [6]. Application of these effects, especially optical properties, for sensor technologies 
could be a novel trend of sensorics. Optical methods have good advantages such as higher preciseness and 
low energy consumption. 
Early, we have developed the immune biosensor based on the SPR and intended for the bovine 
leucosis diagnostics [7]. The traditional immune methods have high specificity and sensitivity, but they 
take a lot of time, and require additional parameters such as the labelled molecules [7]. This drawback can 
be overcome with the use of the modern instrumental analytical devices based on the biosensor 
technology [7]. 
2. Experimental
Previously, it was shown good capacities of SiO2 hydro gels, based on commercial SiO2 nanofibers, 
for biosensors [6]. In the presented work commercial TiO2 nanoparticles (Sigma Aldrich, particle size 32 
nm) were used as biosensor template. TiO2 nanoparticles were solved in water to prepare sols. TiO2 layers 
were formed on glass substrates by dropping TiO2 sols and drying at room temperature. Post annealing 
treatment at 300 0C for 1 hour was provided to remove water from the samples. Structural properties of 
the obtained samples were studied with SEM method. Fabrication of sensitive layer was performed by 
immobilization of Ag on TiO2 surface. TiO2 nanostructures were exposed to water solution of leucosis 
antigens (Ag) for ten minutes and then were washed two times in distilled water and dried in air at 
temperature 40 0C. The backside of TiO2 sample was sealed to prevent immobilization of Ag on it. 
Leucosis antibodies (Ab) were deposited on TiO2-Ag surface from water solutions with different 
concentrations. Photoluminescence (PL) spectra were measured by setup, presented in Fig. 1. The 
luminescence was stimulated by UV laser LCS-DTL-374QT with excitation ZDYHOHQJWKȜ QP7KH
emission spectra were amplified and recorded in the wavelength range 370-800 nm. 
340   R. Viter et al. /  Procedia Engineering  47 ( 2012 )  338 – 341 
3. Results and discussion
SEM measurements showed that nanoparticles formed high surface area porous structure (Fig.2). The 
obtained structure was suitable platform for immobilization of biological species. 
PL spectrum of TiO2 nanoparticles had broad peak centered at 514 nm (Fig.3). The immobilization of 
leucosis Ag on TiO2 surface led to the changes in PL intensity and PL peaks positions after 
immobilization of Ag onto TiO2 nanoparticles surface (Fig.3a). It was found that after Ag immobilization 
PL spectra was shifted to shorter wavelengths. It can be a proof of formation links TiO2-Ag. Increase of 
PL intensity could result from charge transfer between Ag molecules and conductance band of TiO2. UV-
shift of PL maximum can be explained by additional dipole-dipole interaction, what can change energetic 
position of recombination centres into TiO2.
              
Fig.1. Photoluminescence setup.                                                          Fig.2. SEM image of TiO2 nanostructures, deposited on glass.
PL spectra of TiO2-Ag biosensor, measured under different Ab concentrations are shown in fig. 3b. It 
was found that PL intensity decreased with Ab concentration. At the same time, peak position moved to 
higher wavelengths.
Thus, the biosensor response to leucosis Ab can be a function of two parameters: PL intensity and 
position of PL peak. To analyze the sensor response we calculated the changes biosensor signal S as
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Fig. 3. PL spectra of TiO2 nanoparticles: (a) before and after immobilization of antigens (Ag); (b) under different concentrations 
of antibodies (Ab).
The changes of peak position after adsorption of Ab were calculated in by following equation: 
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AbAg OOO  '            (2)
where ȜAg and ȜAb are PL peak’s positions of TiO2 nanostructures with immobilized leucosis antigens 
before and after interaction with leucosis antibodies, correspondently. The results, obtained with the use 
of equations (1), (2) are plotted in figures 4a and 4b, correspondently. The analysis of obtained results 
showed that the changes of biosensor parameters had similar behavior. The obtained experimental curves 
increased at the range of Ab concentrations c 0.002-0.008 mg/ml. The further increase of Ab 
concentration led to saturation of the signal changes. 
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Fig. 4. Response of the biosensor signal to different concentrations of antibodies (Ab) (a); The changes of PL peak position of the 
biosensor vs different concentrations of antibodies (Ab) (b)
Conclusion
Novel photoluminescence biosensor based on TiO2 nanoparticles for leucosis detection has been 
developed. The biosensor response to leucosis antibodies is a function of PL intensity and peak position. 
The obtained biosensors can operate in the range of leucosis antibody concentrations 0.002-0.006 mg/ml.  
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